Hemogenyx Pharmaceuticals Plc

HEMO.L | LSE | 0 Sledující

177.50p

0.00%

0.00p

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 GBP	12/31/2023 GBP	12/31/2022 GBP	12/31/2021 GBP
Total revenue	0 -	0 -	0 -	0 -
Cost of revenue	639 -0.99%	646 -75.16%	2,600 +816.55%	284 -
Gross profit	-639 +0.99%	-646 +75.16%	-2,600 -816.55%	-284 -
Operating expense	5,087 +3.55%	4,913 +67.63%	2,931 +15.07%	2,547 -
Operating income	-5,727 -3.02%	-5,559 -239.05%	3,998 +247.91%	-2,703 -
Pretax Income	-5,625 +15.99%	-6,696 -67.96%	-3,987 +21.95%	-5,108 -
Tax Provision	0 -	0 -100.00%	361 -85.04%	2,414 -
Net income	-5,619 +16.01%	-6,691 -53.87%	-4,348 +42.20%	-7,523 -
EPS	-1.7 -28,713.56%	-0.01 -34.09%	-0 +54.64%	-0.01 -
Diluted EPS	-1.7 -28,713.56%	-0.01 -34.09%	-0 +54.64%	-0.01 -
Average Shares	3,301 -99.71%	1,129,228 +15.26%	979,749 +26.59%	773,952 -
Diluted Average Shares	3,301 -99.71%	1,129,137 +15.25%	979,749 +26.59%	773,952 -
EBIT	-5,354 +16.09%	-6,381 -60.03%	-3,987 -58.66%	-2,513 -
EBITDA	-4,715 +17.79%	-5,735 -67.54%	-3,423 -43.42%	-2,387 -

Soubory cookie používáme ke zlepšení prohlížení na webu.